1. Home
  2. AXGN vs AAPG Comparison

AXGN vs AAPG Comparison

Compare AXGN & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$48.47

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$19.00

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXGN
AAPG
Founded
N/A
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
2013
2024

Fundamental Metrics

Financial Performance
Metric
AXGN
AAPG
Price
$48.47
$19.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$42.33
$48.40
AVG Volume (30 Days)
1.1M
3.7K
Earning Date
04-28-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$225,208,000.00
N/A
Revenue This Year
$20.57
$290.34
Revenue Next Year
$16.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.21
N/A
52 Week Low
$13.64
$16.36
52 Week High
$49.93
$48.45

Technical Indicators

Market Signals
Indicator
AXGN
AAPG
Relative Strength Index (RSI) 65.83 55.27
Support Level $29.48 $18.56
Resistance Level N/A $20.40
Average True Range (ATR) 2.65 0.42
MACD 0.66 0.15
Stochastic Oscillator 88.91 92.75

Price Performance

Historical Comparison
AXGN
AAPG

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: